There is no need to include special inspection methods for Chinese herbal medicines and Chinese patent medicines in the appendix of the second edition of Pharmacopoeia, such as prescription preparations, Chinese herbal medicines and decoction pieces, appendix III (2005 edition), control extracts, etc.
Like high performance liquid phase, gas phase and thin layer, they are basically used, but the methods and conditions are different. When you don't need to do the contents of Chinese herbal medicines, you should read the text with one pharmacopoeia in your left hand and the appendix with two pharmacopoeias in your right hand.
People's Republic of China (PRC) Pharmacopoeia (China Pharmacopoeia for short) was published by China Medical Science and Technology Press on June 5, 20/KLOC-0, and was created by the State Pharmacopoeia Committee.
China Pharmacopoeia is published in four parts: one part contains medicinal materials and decoction pieces, vegetable oil and extracts, prescription preparations and single-flavor preparations; The second part includes chemicals, antibiotics, biochemical drugs and radioactive drugs; Three collections of biological products; Four general principles of collection and loading, including: general principles of preparations, inspection methods, guiding principles, general principles related to reference substances and test solutions, pharmaceutical excipients, etc.
On July 2, 2020, the State Administration of Pharmaceutical Products and the National Health and Wellness Commission issued an announcement, officially announcing the 2020 edition of People's Republic of China (PRC) Pharmacopoeia. The new edition of China Pharmacopoeia was officially implemented on February 30th, 2020. The new edition of China Pharmacopoeia added 3 19 species, revised 3 177 species, no longer included 10 species, and adjusted and merged 4 species to include 591/kloc-0 species.